| 臺大學術典藏 |
2022-06-27T07:06:50Z |
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
|
Yuan A.; Yang P.-C.; CHONG-JEN YU; Chen W.-J.; Lin F.-Y.; Kuo S.-H.; Luh K.-T. |
| 臺大學術典藏 |
2022-06-27T07:06:49Z |
Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer
|
Yuan A.; CHONG-JEN YU; Chen W.-J.; Lin F.-Y.; Kuo S.-H.; Luh K.-T.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:49Z |
Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR
|
Yuan A.; CHONG-JEN YU; Luh K.-T.; Chen W.-J.; Lin F.-Y.; Kuo S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:48Z |
Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer
|
Yuan A.; CHONG-JEN YU; Kuo S.-H.; Chen W.-J.; Lin F.-Y.; Kwen-Tay, Luh, Yang P.-C.; Lee Y.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:48Z |
Expression of integrins in human cultured mesothelial cells: The roles in cell-to-extracellular matrix adhesion and inhibition by RGD-containing peptide
|
Liaw Y.-S.; CHONG-JEN YU; Shun C.-T.; Lee Y.-C.; Kuo S.-H.; Luh K.-T.; Yang P.C. |
| 臺大學術典藏 |
2022-06-27T07:06:47Z |
Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion
|
CHONG-JEN YU; Shew J.-Y.; Liaw Y.-S.; Kuo S.-H.; Luh K.-T.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:47Z |
Acute respiratory distress syndrome in a woman with heroin and methamphetamine misuse
|
Yeh P.-S.; Yuan A.; CHONG-JEN YU; Kuo S.-H.; Luh K.-T.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:46Z |
Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer
|
Yuan A.; CHONG-JEN YU; Luh K.-T.; Kuo S.-H.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:40Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.; Yang C.-H.; CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:39Z |
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients
|
Yuan A.; CHONG-JEN YU; Shun C.-T.; Luh K.-T.; Kuo S.-H.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:39Z |
Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma
|
Chen K.-Y.; Chang C.-H.; CHONG-JEN YU; Kuo S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:34Z |
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer
|
Chen K.-Y.; Lee L.-N.; CHONG-JEN YU; Lee Y.-C.; Kuo S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:33Z |
Antibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary disease
|
Lai C.-C.; Lee L.-N.; CHONG-JEN YU; Hseuh P.-R.; Yang P.-C.; Kuo S.-H.; Luh K.-T. |
| 臺大學術典藏 |
2022-06-27T07:06:28Z |
Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response
|
Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:26Z |
Imprint cytology improves accuracy of computed tomography-guided percutaneous transthoracic needle biopsy
|
Chang Y.-C.; CHONG-JEN YU; Lee W.-J.; Kuo S.-H.; Hsiao C.-H.; Jan I.-S.; Hu F.-C.; Liu H.-M.; Chan W.-K.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:25Z |
Cytologically proven meningeal carcinomatosis in patients with lung cancer: Clinical observation of 34 cases
|
Chuang T.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang P.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2022-06-27T07:06:21Z |
Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer
|
Chen C.-H.; Gow C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu Y.-C.; Lee W.-Y.; Yang P.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2022-06-27T07:00:04Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; CHONG-JEN YU; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2022-06-27T06:59:44Z |
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
|
Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; CHONG-JEN YU; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-06-10T06:11:14Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
ZHONG-ZHE LIN; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L. |
| 臺大學術典藏 |
2022-06-10T06:11:13Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
Yang S.-H.; ZHONG-ZHE LIN; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-06-10T06:11:01Z |
The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases
|
Chiang Y.; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; ZHONG-ZHE LIN; Lan K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-06-10T06:10:55Z |
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
|
Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; ZHONG-ZHE LIN; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-05-05T08:48:50Z |
Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study
|
Chen J.L.-Y.; Shen C.-W.; CHIA-CHUN WANG; Huang Y.-S.; Chen J.-P.; Chiang C.-H.; Lin Y.-L.; Kuo S.-H.; Wang C.-W. |
| 臺大學術典藏 |
2022-05-05T03:09:25Z |
Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma
|
Chen J.L.-Y.; Cheng J.C.-H.; Kuo S.-H.; Chen C.-A.; Lin M.-C.; CHAO YUAN HUANG |
| 臺大學術典藏 |
2022-05-05T03:09:23Z |
Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy
|
Chen J.L.-Y.; CHAO YUAN HUANG; Huang Y.-S.; Chen R.-J.; Wang C.-W.; Chen Y.-H.; Cheng J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-05-05T03:09:22Z |
Preoperative Prognostic Neurologic Index for Glioblastoma Patients Receiving Tumor Resection
|
Liang H.-K.; Wang C.-W.; Tseng H.-M.; CHAO YUAN HUANG; Lan K.-H.; Chen Y.-H.; You S.-L.; Cheng J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-05-05T03:09:20Z |
Extended-field bone marrow sparing radiotherapy for primary chemoradiotherapy in cervical cancer patients with para-aortic lymphadenopathy: Volumetric-modulated arc therapy versus helical tomotherapy
|
Chen J.L.-Y.; Wang M.-C.; Huang Y.-S.; CHAO YUAN HUANG; Pan C.-K.; Hsu C.-Y.; Lan K.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2022-05-05T03:09:19Z |
Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: A retrospective study
|
Chen J.L.-Y.; Huang Y.-S.; CHAO YUAN HUANG; Hsu C.-Y.; Lan K.-H.; Cheng W.-F.; Kuo S.-H. |
| 臺大學術典藏 |
2022-05-05T03:09:16Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; CHAO YUAN HUANG; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2022-04-26T07:50:29Z |
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer
|
Chen J.L.-Y.; Pan C.-K.; Lin Y.-L.; Tsai C.-Y.; Huang Y.-S.; WEN-CHI YANG; Hsu F.-M.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2022-04-26T07:50:29Z |
Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)
|
WEN-CHI YANG; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; Kuo S.-H.; Hsu F.-M. |
| 臺大學術典藏 |
2022-04-25T07:36:16Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; JIA-HAU LIU; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2022-04-25T07:36:11Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-04-14T07:20:22Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-03-25T02:05:46Z |
Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factors
|
SHIH-FAN LAI; Wang C.-W.; Chen Y.-H.; Lan K.-H.; Cheng J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-25T02:05:45Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
SHIH-FAN LAI; Chen Y.-H.; Kuo W.-H.; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; Cheng A.-L.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-25T02:05:45Z |
Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion
|
Liang T.H.-K.; Kuo S.-H.; Wang C.-W.; Chen W.-Y.; Hsu C.-Y.; SHIH-FAN LAI; Tseng H.-M.; You S.-L.; Chen C.-M.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2022-03-25T02:05:44Z |
The extent of edema and tumor synchronous invasion into the subventricular zone and corpus callosum classify outcomes and radiotherapy strategies of glioblastomas
|
Liang H.-K.T.; Chen W.-Y.; SHIH-FAN LAI; Su M.-Y.; You S.-L.; Chen L.-H.; Tseng H.-M.; Chen C.-M.; Kuo S.-H.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2022-03-25T02:05:43Z |
The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation
|
SHIH-FAN LAI; Chen Y.-H.; Liang T.H.-K.; Hsu C.-Y.; Lien H.-C.; Lu Y.-S.; Huang C.-S.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-25T02:05:42Z |
Whether adjuvant radiotherapy is desired for postmastectomy patients with T1�VT2 tumors and 1�V3 positive axillary lymph nodes who received modern systemic therapy?
|
SHIH-FAN LAI; Huang C.-S.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-15T05:39:28Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; WEI-WU CHEN; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
|
Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]
|
SHIH-HUNG YANG; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
